APA

Filippi V., Malamitsi J., Vlachou F., Laspas F., Georgiou E., Prassopoulos V. & Andreou J. (20110408). The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities. : Nuclear medicine communications.

Chicago

Filippi Vasiliki, Malamitsi Joulia, Vlachou Fani, Laspas Fotios, Georgiou Evangelos, Prassopoulos Vasileios and Andreou John. 20110408. The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities. : Nuclear medicine communications.

Harvard

Filippi V., Malamitsi J., Vlachou F., Laspas F., Georgiou E., Prassopoulos V. and Andreou J. (20110408). The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities. : Nuclear medicine communications.

MLA

Filippi Vasiliki, Malamitsi Joulia, Vlachou Fani, Laspas Fotios, Georgiou Evangelos, Prassopoulos Vasileios and Andreou John. The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities. : Nuclear medicine communications. 20110408.